DSM-5 field trials in the United States and Canada, Part II: test-retest reliability of selected categorical diagnoses.
By D. Regier, W. Narrow, D. Clarke, H. Kraemer, S. J. Kuramoto, Emily A. Kuhl, David J. Kupfer. American Journal of Psychiatry, 2013
1,009 citations recorded by the source corpus.
Subfields: Clinical Psychology, Experimental and Cognitive Psychology, Pharmacology
View Paper: https://www.semanticscholar.org/paper/d0af306ad5d05727a375c149367571999727ce42
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Clinical Psychology
In Experimental and Cognitive Psychology
- Eiko I. Fried
- A. Cramer
- Kate H Bentley
- S. Sauer‐Zavala
- J. Bullis
- Sacha Epskamp
- Satrajit S. Ghosh
- Brian Marx
In Pharmacology
Citations in the corpus
- Posttraumatic Stress Disorder in DSM-5: New Criteria, New Measures, and Implications for Assessment (2014, background): “However, it does not appear to affect reliability: In the DSM-5 field trials, PTSD was one of the most reliable of all diagnoses evaluated in adults (Regier et al., 2013).”
- Automated assessment of psychiatric disorders using speech: A systematic review (2019, background): “This obstacle is evidenced by the presence of low inter-rater reliability 26 and test-retest reliability 27 in certain psychiatric diagnoses including major depressive disorder (MDD) that have a low kappa score.”
- Depression is not a consistent syndrome: an investigation of unique symptom patterns in the STAR*D study (2014, neutral): “…for inconsistent findings and recent disappointing results such as the questionable reliability of depression diagnosis in the DSM-5 field trials (Regier et al., 2013), the striking lack of progress in identifying biomarkers associated with depression diagnosis or treatment response (Hek et al.,…”
- The Hierarchical Taxonomy of Psychopathology (HiTOP): A Dimensional Alternative to Traditional Nosologies (2017, neutral): “For example, the DSM–5 Field Trials found that 40% of diagnoses did not meet even a relaxed cutoff for acceptable interrater reliability (Regier et al., 2013), although the same disorders often showed excellent reliability when operationalized dimensionally (Markon et al.”
- Moving Forward: Challenges and Directions for Psychopathological Network Theory and Methodology (2017, background): “Many DSM disorders fail to meet orthodox criteria for validity such as a clear clinical presentation, precise diagnostic boundaries, treatment specificity, and temporal stability (Fried, 2015; Insel, 2013; Kupfer, First, & Regier, 2002; Parker, 2005), and the DSM-5 field trials have documented quest”
- Clinical applications of the functional connectome (2013, neutral): “For comparison, these generally surpass the test–retest reliabilities of diagnostic assessments of the major psychiatric disorders recently documented in the DSM-5 Field Trials (Regier et al., 2013).”
- What is an emotional disorder? A transdiagnostic mechanistic definition with implications for assessment, treatment, and prevention (2019, background): “Equally concerning, field trials for the latest version of the DSM, DSM‐5, have failed to demonstrate strong test–retest reliability for some of the most commonly occurring psychological disorders, such as major depressive disorder (Regier et al., 2013).”
- Maladaptive Daydreaming: Proposed Diagnostic Criteria and Their Assessment With a Structured Clinical Interview (2017, neutral): “In the DSM-5 field trials (Regier et al., 2013), Cohen’s kappa values were generated for 15 adult diagnoses and eight child and adolescent diagnoses: Five had kappa values of .60–.79, nine had values of .40– .59; six had values of .20–.39, and three had values of less than .20.”